Create an Account
  1. Home
  2. Series
  3. DEF BIOLOGIC & SMALL MOLECULE REGIONAL CME VIRTUAL BOOTCAMP November 2021

Hidradentitis Suppurativa Update

Hidradentitis Suppurativa Update
Program Information

The live program has concluded.


If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.

Scroll back to top
Details

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Recognize the epidemiology of Hidradenitis Suppurativa
    • Recognize primary lesions at early stage of disease
    • Implement early diagnosis to prevent morbidity and provide effective treatment outcomes

    • Accreditation

      • Accreditation Statement​ This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC, the Dermatology Education Foundation, and Physician Resources, LLC. Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.​
      • Designation Statement​ Evolve Medical Education, LLC designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits TM. ​ Physicians should claim only the credit commensurate with the extent of their participation in the activity.​
      • PA CONTINUING EDUCATION​ PAs may claim a maximum of .5 Category 1 credits for completing this activity. National Commission on Certification ​of Physician Assistants (NCCPA) accepts AMA PRA Category 1 CreditsTM from organizations accredited by ACCME or a recognized state medical society.​
      • NURSE PRACTITIONER CONTINUING EDUCATION​ The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditsTM  from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.​
      • This activity is designated for .25 pharmacology hours.

    • Faculty and Disclosures

      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

      DISCLOSURE POLICY It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

      The following faculty/staff members have the following financial relationships with commercial interests:J

      oseph Gorelick, MSN, FNP-C has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Bristol Myers Squibb, Beiersdorf, Brickell, Incyte, Journey, and Novartis. Speaker’s Bureau: AbbVie, Beiersdorf, Janssen, Lilly, LEO, Novartis, Pfizer, Prugen, Regeneron Pharmaceuticals, Sun Pharma, and Vyne. Stock Shareholder: 10X Genomics, AbbVie, Alnilam Pharmaceuticals, Bioline Rx, Fortress Biotech, G1 Therapeutics, Guardiant Health, Intuitive Surgical, LTD, Moderna, and Royalty Pharma. ​

      Accreditation and Medical Education Support Disclosure​

       Erin Fletcher of Evolve Medical Education LLC have no real or apparent conflicts of interest to report. ​

      Stacey Moore of Physician Resources, LLC has no real or apparent conflicts of interest to report.​

      ​

    • Disclaimer

      OFF-LABEL STATEMENT This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
      DISCLAIMER The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education, Dermatology Education Foundation, or Physician Resources.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Expiration Date:

    0.75 credits
    Completing the pre-test is required to access this content.
    Completing the pre-survey is required to view this content.

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    LIVE ON REACHMD RADIOBack to live radio
    ReachMD Radio

    Loading...

    00:00
    00:00
      Register

      We're glad to see you're enjoying Evolve Medical Education…
      but how about a more personalized experience?

      Register for free